Clinical Trial Update: Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicates REM-001 photodynamic therapy for cutaneous metastatic breast cancer is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• REM-001 (REM-001)

Snippet

Sponsor: Kintara Therapeutics, Inc. | Conditions: Cutaneous Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING